Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control

Dafne C.A. Quixabeira; Sadia Zafar; Joao M. Santos; Victor Cervera-Carrascon; Riikka Havunen; Tatiana V. Kudling; Saru Basnet; Marjukka Anttila; Anna Kanerva; A. Hemminki

doi:10.3389/fimmu.2021.674400

Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control

Dafne C.A. Quixabeira, Sadia Zafar, Joao M. Santos, Victor Cervera-Carrascon, Riikka Havunen, Tatiana V. Kudling, Saru Basnet, Marjukka Anttila, Anna Kanerva, A. Hemminki

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Artikkeli	674400
Lehti	Frontiers in Immunology
Vuosikerta	12
Sivumäärä	13
ISSN	1664-3224
DOI - pysyväislinkit	https://doi.org/10.3389/fimmu.2021.674400
Tila	Julkaistu - 18 toukok. 2021
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Lisätietoja

cited By 0

Tieteenalat

3122 Syöpätaudit
3111 Biolääketieteet

Pääsy asiakirjaan

10.3389/fimmu.2021.674400Lisenssi: CC BY

fimmu-12-674400Lopullinen julkaistu versio, 2,48 MBLisenssi: CC BY

Siteeraa tätä

Quixabeira, D. C. A., Zafar, S., Santos, J. M., Cervera-Carrascon, V., Havunen, R., Kudling, T. V., Basnet, S., Anttila, M., Kanerva, A., & Hemminki, A. (2021). Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control. Frontiers in Immunology, 12, Artikkeli 674400. https://doi.org/10.3389/fimmu.2021.674400

@article{69022de1d384491c977de68c0cef637a,

title = "Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control",

keywords = "3122 Cancers, 3111 Biomedicine, oncolytic virus, IL-2 variant, anti-tumor immunity, tumor microenvironment (TME), virotherapy in cancer, HIGH-DOSE INTERLEUKIN-2, CELLS",

author = "Quixabeira, {Dafne C.A.} and Sadia Zafar and Santos, {Joao M.} and Victor Cervera-Carrascon and Riikka Havunen and Kudling, {Tatiana V.} and Saru Basnet and Marjukka Anttila and Anna Kanerva and A. Hemminki",

note = "cited By 0",

year = "2021",

month = may,

day = "18",

doi = "10.3389/fimmu.2021.674400",

language = "English",

volume = "12",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media SA",

}

Quixabeira, DCA, Zafar, S, Santos, JM, Cervera-Carrascon, V, Havunen, R, Kudling, TV, Basnet, S, Anttila, M, Kanerva, A & Hemminki, A 2021, 'Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control', Frontiers in Immunology, Vuosikerta 12, 674400. https://doi.org/10.3389/fimmu.2021.674400

TY - JOUR

T1 - Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control

AU - Quixabeira, Dafne C.A.

AU - Zafar, Sadia

AU - Santos, Joao M.

AU - Cervera-Carrascon, Victor

AU - Havunen, Riikka

AU - Kudling, Tatiana V.

AU - Basnet, Saru

AU - Anttila, Marjukka

AU - Kanerva, Anna

AU - Hemminki, A.

N1 - cited By 0

PY - 2021/5/18

Y1 - 2021/5/18

KW - 3122 Cancers

KW - 3111 Biomedicine

KW - oncolytic virus

KW - IL-2 variant

KW - anti-tumor immunity

KW - tumor microenvironment (TME)

KW - virotherapy in cancer

KW - HIGH-DOSE INTERLEUKIN-2

KW - CELLS

U2 - 10.3389/fimmu.2021.674400

DO - 10.3389/fimmu.2021.674400

M3 - Article

SN - 1664-3224

VL - 12

JO - Frontiers in Immunology

JF - Frontiers in Immunology

M1 - 674400

ER -